US Stock MarketDetailed Quotes

OCX OncoCyte

Watchlist
  • 3.1427
  • +0.1127+3.72%
Close Aug 29 16:00 ET
42.01MMarket Cap-741P/E (TTM)

OncoCyte Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

OncoCyte Q2 2024 Earnings Date

Currency：USDAug 8, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
312.37K
104.00K
-208.37K
Miss Est.
-32.53%
-77.54%
-66.71%
EPS
-0.55
-0.36
+0.19
Beat Est.
+48.60%
+66.36%
+34.53%
Analyst Rating
Buy

Jun 30, 2024

OncoCyte Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 102.500K--
--2024/Q3-- / 102.500K--
Aug 8, 20242024/Q2104.000K / 312.370K--
May 15, 20242024/Q1176.000K / 350.000K--
--2023/Q4314.000K / 316.670K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 102.500K--
--2024/Q3-- / 102.500K--
Aug 8, 20242024/Q2104.000K / 312.370K--
May 15, 20242024/Q1176.000K / 350.000K--
--2023/Q4314.000K / 316.670K--

Unlock Free Earnings Estimates

OncoCyte Earnings Reports

  • OncoCyte | 10-Q: Q2 2024 Earnings Report

    Aug 8 16:32 ET

  • OncoCyte | 10-Q: Q1 2024 Earnings Report

    May 15 16:18 ET

  • OncoCyte | 10-K: FY2023 Annual Report

    Apr 16 06:09 ET

  • OncoCyte | 10-Q: Q3 2023 Earnings Report

    Nov 9, 2023 17:19 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg